IgE in the diagnosis and treatment of allergic disease.
Traditionally, the concept of allergy implied an abnormal response to an otherwise benign agent (eg, pollen or food), with an easily identifiable relationship between exposure and disease. However, there are syndromes in which the relationship between exposure to the relevant allergen and the "allergic" disease is not clear. In these cases the presence of specific IgE antibodies can play an important role in identifying the relevant allergen and provide a guide to therapy. Good examples include chronic asthma and exposure to perennial indoor allergens and asthma related to fungal infection. Finally, we are increasingly aware of forms of food allergy in which the relationship between exposure and the disease is delayed by 3 to 6 hours or longer. Three forms of food allergy with distinct clinical features are now well recognized. These are (1) anaphylactic sensitivity to peanut, (2) eosinophilic esophagitis related to cow's milk, and (3) delayed anaphylaxis to red meat. In these syndromes the immunology of the response is dramatically different. Peanut and galactose α-1,3-galactose (alpha-gal) are characterized by high- or very high-titer IgE antibodies for Ara h 2 and alpha-gal, respectively. By contrast, eosinophilic esophagitis is characterized by low levels of IgE specific for milk proteins with high- or very high-titer IgG4 to the same proteins. The recent finding is that patients with alpha-gal syndrome do not have detectable IgG4 to the oligosaccharide. Thus the serum results not only identify relevant antigens but also provide a guide to the nature of the immune response.
University of Virginia, Asthma and Allergy Disease Center, Charlottesville, Va. Electronic address: tap2z@virginia.edu.
Thomas A E
TAE
Platts-Mills
University of Virginia, Asthma and Allergy Disease Center, Charlottesville, Va.
Alexander J
AJ
Schuyler
Nationwide Children's Hospital, Center for Innovation in Pediatric Practice, Columbus, Ohio.
Elizabeth A
EA
Erwin
Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, NC.
Scott P
SP
Commins
University of Virginia, Asthma and Allergy Disease Center, Charlottesville, Va.
Judith A
JA
Woodfolk
D000485:Allergens / Q000276:immunology; D000818:Animals; D001249:Asthma / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D015415:Biomarkers; D005658:Fungi / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis* / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D007114:Immunization; D007118:Immunoassay / Q000379:methods / Q000592:standards; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D012307:Risk Factors
D000485:Allergens; D015415:Biomarkers; D007073:Immunoglobulin E
Asthma; IgE antibodies; IgG(4); allergen particles; alpha-gal; eosinophilic esophagitis